Press Releases
 
What's Rad 140?

, 10 August 2018 -- Testolone (RAD140) is a selective androgen receptor modulator (SARM) being developed by the pharmaceutical company Radius for the treatment of breast cancer and muscle wasting in postmenopausal women. Testolone is very new to the commercial market with its initial discovery in 2010. The initial studies, company reports, and anecdotal user reviews have been highly promising for the muscle building properties of RAD 140.

In the at present readily available SARMs, RAD 140 is definitely the most lately created. Should you be new towards the world of SARMs, you could possibly have realized that a lot of tend to have unusual names consisting of a series of letters and numbers. These analysis chemical substances haven't been authorized for official use in the medical field. This is the reason they may be still being identified by abbreviations of their respective developers’ names. RAD 140 is currently being created by a corporation referred to as Radius Health, which explains the “RAD” portion with the name. Several of those compounds also have unofficial names that sound comparable towards the names of steroids - as an illustration, just as RAD 140 can also be known as testolone, LGD-4033 is called ligandrol. Get more details about <a href="https://www.health-informatics.org/testolone-rad140-review/">https://www.health-informatics.org/testolone-rad140-review/</a

Non-steroidal SARMs have been about for decades (and steroidal SARMs even longer). This supplement was announced to the study planet in 2010, making it very new in comparison to a few of the significantly older SARMs. For the reason that of its common newness, you will discover far fewer studies on it than have been accomplished on older SARMs, like the well known ostarine. Ostarine and older SARMs have been tested somewhat extensively on humans. Most RAD 140 studies happen to be performed on animals, however the final results are nevertheless promising. Further animal study is likely to cause clinical studies in humans, which in turn will deliver the bodybuilding neighborhood with beneficial details concerning dosage as well as other variables.

Whilst considerably of your common research on SARMs focuses on their mechanism of action and on their effects as a complete, skilled SARM users have noted that unique SARMs have slight rewards in particular places. For instance, ostarine is normally generally known as getting particularly valuable as a cutting and recomp drug. Ligandrol (also named LGD 4033) is well-suited to bulking.

There's much less of a common consensus on RAD 140, just because this is such a brand new supplement. But using a 90:1 anabolic to androgenic ratio, it has the possible to make muscle development comparable to testosterone. Some users have noted that RAD 140 appears to enhance speed and endurance as well. This supplement shows possible as an all-around efficiency enhancer also as the prospective for creating muscle.

# # #


Submitted by Kyle Crum on Friday, 10 August 2018 at 2:53 PM
Category: Health Care & Medical
 
Related News

Agricultural Biotechnology Market Insights, Share, Growth Drivers and Forecast by 2023
Tuesday, 23 Oct 2018

Polymerase Chain Reaction Market: Emergence of Digital PCR Systems to Boost the Growth
Monday, 22 Oct 2018

Radiopharmaceuticals Market to Expand at a CAGR of 5.4% over 2017-2024
Monday, 22 Oct 2018

Oral Thin Film Drugs Market Size, Application Analysis, Regional Outlook, 2017 - 2025
Monday, 22 Oct 2018

Compression Therapy Market: Increasing Popularity of Sports and Other Activities Boosting Market
Monday, 22 Oct 2018

Related Events

92nd Annual Clinical Reviews 2018
Monday, 22 Oct 2018

2nd Annual NASH Summit Europe
Monday, 22 Oct 2018

Precision CRISPR: Drug Discovery and Gene Therapy London 2018
Monday, 22 Oct 2018

Gene Therapy for Rare Disorders Europe Summit
Monday, 22 Oct 2018

Targeted Protein Degradation Summit
Tuesday, 23 Oct 2018

Latest News

Looking for a professional company in London offering best cleaning services? Try SkyCleaners!
Tuesday, 23 Oct 2018

Quit smoking and switch to vaping with pod systems USA!!!
Tuesday, 23 Oct 2018

XChatlines can read the pulse of the new generation
Tuesday, 23 Oct 2018

Freedom Montessori School–Best and Affordable Preschool for Your Kid
Tuesday, 23 Oct 2018

Centerville Preschool Bringing in the True Happiness in your Child’s Life
Tuesday, 23 Oct 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 23 October 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • American Manufacturing Strategies Summit 2018, San Diego
  • American Supply Chain Management Strategies Summit 2018, San Diego
  • Argus Biofuels and Carbon Markets Summit
  • SMPTE 2018 Annual Technical Conference and Exhibition (SMPTE 2018)
  • 2nd Annual NASH Summit Europe

  • Latest Jobs
    Sorry, there are currently no entries posted here.